GE Healthcare Technologies Inc (NASDAQ:GEHC) reported fourth-quarter 2023 sales of $5.21 billion, up 5% Y/Y on an organic basis, slightly beating the consensus of $5.09 billion, driven by volume and price.
Net income attributable to GE HealthCare was $403 million versus $554 million for the prior year, and Adjusted EBIT was $837 million versus $844 million.
The company’s total book-to-bill was strong at 1.05 times. Total company orders increased 3% organically year-over-year.
Also Read: General Electric Gears Up For Vernova Spin-Off Amid GEHC Stock …
Leave a Reply